Atea Pharmaceuticals Inc
NASDAQ:AVIR

Watchlist Manager
Atea Pharmaceuticals Inc Logo
Atea Pharmaceuticals Inc
NASDAQ:AVIR
Watchlist
Price: 3.6 USD -1.37%
Market Cap: 281.3m USD

Wall Street
Price Targets

AVIR Price Targets Summary
Atea Pharmaceuticals Inc

Wall Street analysts forecast AVIR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVIR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
68% Upside
Average
Price Target
6.12 USD
70% Upside
Highest
Price Target
6.3 USD
75% Upside
Atea Pharmaceuticals Inc Competitors:
Price Targets
VIRP
Virbac SA
15% Upside
ERIS
Eris Lifesciences Ltd
22% Upside
OMER
Omeros Corp
107% Upside
600276
Jiangsu Hengrui Pharmaceuticals Co Ltd
35% Upside
185750
Chong Kun Dang Pharmaceutical Corp
39% Upside
086450
Dongkook Pharmaceutical Co Ltd
49% Upside
OGI
OrganiGram Holdings Inc
49% Upside
300119
Tianjin Ringpu Bio-Technology Co Ltd
39% Upside

Revenue
Forecast

Revenue Estimate
Atea Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Atea Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-29%
Average Miss

Net Income
Forecast

Net Income Estimate
Atea Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVIR's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for AVIR is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Back to Top